清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Preventing viral relapse with prophylactic tenofovir in hepatitis B carriers receiving chemotherapy: a phase IV randomized study in Taiwan

医学 内科学 乙型肝炎病毒 乙型肝炎 胃肠病学 乙型肝炎表面抗原 随机对照试验 累积发病率 肝病学 化疗 免疫学 病毒 移植
作者
Chao‐Wei Hsu,Shin‐Cheh Chen,Po‐Nan Wang,Hung‐Ming Wang,Yi-Cheng Chen,Chau‐Ting Yeh
出处
期刊:Hepatology International [Springer Science+Business Media]
被引量:1
标识
DOI:10.1007/s12072-023-10635-5
摘要

This study aimed to compare the efficacy of shorter vs. longer tenofovir disoproxil fumarate (TDF) prophylaxis in preventing hepatitis B virus (HBV) relapse in cancer patients with chronic hepatitis B (CHB) undergoing chemotherapy. This phase IV, prospective randomized trial enrolled cancer patients with CHB from 2014 to 2019 in Taiwan. Included patients were randomized to receive either 24- (Arm A) or 48-week (Arm B) post-chemotherapy TDF and compared for cumulative incidence of virological and clinical relapse. Logistic regressions were conducted to determine the factors associated with HBV relapse. One hundred patients were randomized, and 41 patients in Arm A and 46 in Arm B completed the TDF treatment. No significant difference was found in cumulative incidence of virological relapse (Arm A: 94.4%, Arm B: 93.1%, p = 0.110) or clinical relapse among patients with baseline HBV DNA > 2000 IU/mL (Arm A: 38.9%, Arm B: 26.7%, p = 0.420) between the two arms. High baseline HBV DNA ≥ 10,000 IU/mL (OR = 51.22) and HBsAg ≥ 1000 IU/mL (OR = 8.64) were independently associated with an increased virological relapse. Alanine aminotransferase (ALT), serum phosphorus, vitamin D, and estimated glomerular filtration rate (eGFR) remained stable throughout the study. The 24-week preventative TDF has comparable efficacy to the 48-week treatment in virologic and clinical relapse. High baseline HBsAg or HBV DNA is associated with a higher risk of HBV relapse. These findings imply a 24-week duration of TDF treatment with a close monitor for patients with a high baseline viral load. Hepatitis B virus infection is a prominent cause of liver cancer and chronic liver disease and affected millions of people worldwide. When HBV-infected people are exposed to immunosuppressive medication or chemotherapy for cancer, the chance of HBV reactivation rises considerably. This trial showed 24-week tenofovir disoproxil fumarate (TDF) may be sufficient for preventing HBV relapse in cancer patients receiving chemotherapy. NCT02081469.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
17秒前
Balance Man完成签到 ,获得积分10
17秒前
隐形曼青应助Ggap1采纳,获得10
23秒前
小余同学发布了新的文献求助10
24秒前
weiweiwu12完成签到,获得积分10
43秒前
青出于蓝蔡完成签到,获得积分10
48秒前
满意机器猫完成签到 ,获得积分10
1分钟前
霜二完成签到 ,获得积分10
1分钟前
AZN完成签到 ,获得积分10
1分钟前
姆姆没买完成签到 ,获得积分10
1分钟前
今后应助阿尔法贝塔采纳,获得10
1分钟前
charih完成签到 ,获得积分10
1分钟前
陌上之心完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
宇文雨文完成签到 ,获得积分10
1分钟前
1分钟前
橙子完成签到 ,获得积分10
1分钟前
xiaofeixia完成签到 ,获得积分10
1分钟前
jlwang完成签到,获得积分10
1分钟前
2分钟前
2分钟前
lty完成签到,获得积分20
2分钟前
孟寐以求完成签到 ,获得积分10
2分钟前
2分钟前
fkdbdy发布了新的文献求助10
2分钟前
朴子完成签到 ,获得积分10
2分钟前
香蕉觅云应助勇往直前采纳,获得10
2分钟前
勇往直前完成签到,获得积分10
2分钟前
widesky777完成签到 ,获得积分0
2分钟前
carne完成签到,获得积分10
2分钟前
2分钟前
上善若水完成签到 ,获得积分10
2分钟前
勇往直前发布了新的文献求助10
2分钟前
Tumbleweed668完成签到,获得积分20
3分钟前
科研狗完成签到 ,获得积分0
3分钟前
科研通AI2S应助科研通管家采纳,获得10
3分钟前
Dongjie完成签到,获得积分10
3分钟前
蔡勇强完成签到 ,获得积分10
3分钟前
雷小牛完成签到 ,获得积分10
3分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968532
求助须知:如何正确求助?哪些是违规求助? 3513358
关于积分的说明 11167309
捐赠科研通 3248700
什么是DOI,文献DOI怎么找? 1794453
邀请新用户注册赠送积分活动 875030
科研通“疑难数据库(出版商)”最低求助积分说明 804664